病毒性胃肠炎 中国就医指南

Viral gastroenteritis, commonly known as the 'stomach flu,' is an acute, self-limiting inflammation of the stomach and intestines caused primarily by enteric viruses. Despite its colloquial name, it is not related to influenza virus; rather, it is most frequently triggered by norovirus (responsible for ~50–70% of adult cases globally), rotavirus (predominant in children under 5), adenovirus, astrovirus, and sapovirus. Pathogenesis involves viral attachment to enterocytes in the small intestine, leading to villous blunting, impaired nutrient and fluid absorption, and activation of the enteric nervous system—resulting in secretory diarrhea, vomiting, and abdominal cramps. Viral replication induces localized epithelial damage and transient immune-mediated inflammation, but systemic invasion is rare. Epidemiologically, viral gastroenteritis affects an estimated 1.7 billion people annually worldwide, causing over 500,000 deaths—primarily among children under five in low-resource settings. In high-income countries like China, incidence remains high due to dense urban populations, shared dining practices, and seasonal peaks (norovirus surges in winter; rotavirus in late winter–early spring). Risk factors include young age (<5 years), advanced age (>65), immunocompromised status (e.g., post-transplant, HIV), institutional living (nursing homes, dormitories), poor hand hygiene, consumption of contaminated food or water, and travel to endemic areas. While most cases resolve spontaneously within days, complications—including severe dehydration, electrolyte imbalances (hypokalemia, metabolic acidosis), acute kidney injury, and hospitalization—are more common in infants, elderly, and chronically ill patients. Quality of life impact is substantial yet often underestimated: acute symptoms cause significant work/school absenteeism (averaging 2–3 days per episode), caregiver burden, anxiety around contagion, and disruption of daily routines. Recurrent norovirus infections—due to short-lived, strain-specific immunity—can lead to persistent psychosocial stress, especially among healthcare workers and parents of young children. In China, rising awareness and improved diagnostics have increased outpatient reporting, though underreporting remains widespread due to mild presentation and lack of routine stool testing. Public health efforts increasingly emphasize prevention—handwashing with soap (alcohol-based sanitizers are less effective against norovirus), surface disinfection with chlorine-based agents, food handler exclusion during illness, and rotavirus vaccination (included in China’s expanded program immunization since 2020 for infants). Early oral rehydration therapy (ORT) remains the cornerstone of management, reducing mortality by >90% when appropriately administered.

# 病毒性胃肠炎治疗方案与费用明细（消化内科）

一、非手术/保守治疗（适用绝大多数患者）

• •基础补液支持：口服补液盐（ORS）Ⅲ型，3–5天疗程；费用：15–30元
• •对症药物：蒙脱石散（国产/进口）、益生菌（双歧杆菌三联/四联）、止吐药（昂丹司琼片）；费用区间：40–180元
• •检验检查：粪便轮状病毒/诺如病毒抗原检测（胶体金法费用：120–260元

二、住院强化治疗（适用于中重度脱水、婴幼儿、老年人）

• •含静脉补液（生理盐水+葡萄糖+钾氯）、心电监护、动态电解质监测；住院3–5天；费用：2,800–6,500元（含床位、护理、输液耗材）

三、特殊复杂情况处理

• •合并严重电解质紊乱（低钾/低钠昏迷）或肠梗阻样表现：需消化内镜排除器质性病变（如结肠镜检查），费用：2,200–3,600元（含麻醉、病理送检）
• •免疫缺陷患者反复感染：加做粪便宏基因组测序（mNGS），费用：2,800–4,500元

四、方案快速选择指南

• •轻症成人（自限性）：首选门诊口服补液+益生菌，总费用≤300元
• •婴幼儿/高龄/慢性病患者：建议住院观察，预算3,000–6,500元
• •反复发作或诊断不明者：启动病毒mNGS+结肠镜，预算6,000–9,000元